Emory Cardiac Toolbox

by Syntermed
VISIT OFFICIAL WEBSITE →
Disclaimer: This page is an independent third-party listing and is not affiliated with, sponsored by, or endorsed by Emory Cardiac Toolbox or Syntermed. All product names, logos, and brands are property of their respective owners.

OVERVIEW

Advanced software for quantitative cardiac SPECT and PET analysis, featuring AI-powered decision support and automated reporting for nuclear cardiology.

The Emory Cardiac Toolbox™ (eCTb™), developed by Ernest V. Garcia, PhD, at Emory University and commercialized by Syntermed, is one of the most widely applied cardiac imaging systems in the world. It provides advanced cardiovascular quantification for both SPECT and PET studies, offering 2D/3D image displays and a suite of specialized analysis tools.

Key Capabilities & Features

  • AI-Powered Clinical Decision Support (Syntermed IDS™): The system is equipped with an image decision support system (IDS) that uses over 230 heuristic rules to perform automatic interpretation of SPECT and PET myocardial perfusion studies. It generates justifications for the diagnosis, which the physician can review and modify.
  • Automated Natural Language Reporting (SmartReport™): This feature automatically propagates an intelligent, structured report for perfusion, function, and viability, converting quantitative scores into natural language text to expedite the reporting process.
  • Multi-Modality Analysis: Quantifies and displays myocardial perfusion, function, and LV dyssynchrony studies. It supports SPECT, PET, and CT (for Coronary Artery Calcium Scoring).
  • SyncTool™ for LV Dyssynchrony: A phase analysis software tool used to evaluate the benefits of Cardiac Resynchronization Therapy (CRT) in heart failure patients, using the same data from perfusion studies.
  • Specialized Analysis: Includes integrated tools for Amyloidosis Analysis (quantifying myocardial uptake with specific tracers) and FlowTool™ for computing Absolute Blood Flow and Myocardial Flow Reserve (CFR).
  • Workflow & Integration: Offers improved workflow efficiency, easy, automatic EMR integration, and cloud-based remote reading/reporting via Syntermed Live™.

Target Users and Use Cases

The primary users are Cardiologists and Nuclear Cardiology Technologists in hospitals and imaging centers. The software addresses critical questions like the presence of coronary artery disease, the diagnosis and treatment of heart failure, and the prediction of patient response to specific cardiac therapies.

RATING & STATS

Customers
30,000+
Founded
1998

KEY FEATURES

  • AI-Powered Clinical Decision Support (Syntermed IDS™)
  • Automated Natural Language Reporting (SmartReport™)
  • Quantitative SPECT and PET Analysis
  • LV Dyssynchrony Analysis (SyncTool™)
  • Cardiac Amyloidosis Analysis
  • Myocardial Blood Flow and Coronary Artery Calcium Scoring
  • Cloud-based Remote Reading (Syntermed Live™)
  • EMR Integration

PRICING

Model: enterprise
Pricing is not publicly disclosed and is typically based on an enterprise licensing model, often bundled with OEM imaging systems or a direct license from Syntermed.

TECHNICAL DETAILS

Deployment: cloud, on_premise
Platforms: web, windows
🔌 API Available

USE CASES

Diagnosis of Coronary Artery DiseaseHeart Failure Diagnosis and Treatment PlanningPredicting Response to Cardiac Resynchronization Therapy (CRT)Quantitative Nuclear Cardiology ReportingCardiac Amyloidosis Evaluation

INTEGRATIONS

General Electric (GE)SiemensPhilipsPACS SystemsEMR SystemsASNC ImageGuide Registry

COMPLIANCE & SECURITY

Compliance:
FDA 510(k)HIPAAISO 13485:2016CE Mark
Security Features:
  • 🔒Encryption (at rest and in flight)
  • 🔒Access Control
  • 🔒Logging and Monitoring
  • 🔒Contingency/Disaster Recovery Plan

SUPPORT & IMPLEMENTATION

Support: email, phone, 24/7 support
Target Company Size: medium, enterprise
TRAINING AVAILABLE

PROS & CONS

✓ Pros:
  • +Proven diagnostic accuracy comparable to expert nuclear cardiologists
  • +Comprehensive multi-modality analysis (SPECT, PET, CT)
  • +FDA 510(k) cleared AI/Decision Support for automated reporting
  • +High workflow efficiency with EMR integration and cloud-based access
  • +Widely adopted globally with over 30,000 licenses
✗ Cons:
  • -Pricing not publicly available (enterprise model)
  • -Requires specialized nuclear cardiology hardware/data

ABOUT SYNTERMED

Other software by Syntermed:
Syntermed Emory Toolbox (Cardiology Software SystemsNuclear cardiology (SPECT, PET))
aPROMISE (Nuclear Medicine & Molecular ImagingPET/CT analysis platforms)

BROWSE SOFTWARE IN CARDIAC NUCLEAR MEDICINE